Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase in COVID-19 Patients With Acute Pulmonary Embolism
NCT04558125Phase 4Terminated
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Sep 2020
- Primary completion
- Jul 2021
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of tenecteplase in pulmonary embolism (PE), sponsored by Cedars-Sinai Medical Center. Started Sep 2020; status: terminated.
02
Drugs
tenecteplase
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT04558125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04558125.